Dose-dependent effects of rosuvastatin on circulating microRNAs-27a and 221 levels in patients with coronary artery disease with type 2 diabetes mellitus
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Lipid-Lowering Agents
Session:
Pharmacology and pharmacotherapy e-posters
